The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
Open accessAbstract
BACKGROUND: The survival of patients with diffuse large-B-cell lymphoma after chemotherapy is influenced by molecular features of the tumors. We used the gene-expression profiles of these lymphomas to develop a molecular predictor of survival. METHODS: Biopsy samples of diffuse large-B-cell lymphoma from 240 patients were examined for gene expression with the use of DNA microarrays and analyzed for genomic abnormalities. Subgroups with distinctive gene-expression profiles were defined on the basis of hierarchical clustering. A molecular predictor of risk was constructed with the use of genes with expression patterns that were associated with survival in a preliminary group of 160 patients and was then tested in a validation group of 80 patients. The accuracy of this predictor was compared with that of the international prognostic index. RESULTS: Three gene-expression subgroups--germinal-center B-cell-like, activated B-cell-like, and type 3 diffuse large-B-cell lymphoma--were identified. Two common oncogenic events in diffuse large-B-cell lymphoma, bcl-2 translocation and c-rel amplification, were detected only in the germinal-center B-cell-like subgroup. Patients in this subgroup had the highest five-year survival rate. To identify other molecular determinants of outcome, we searched for individual genes with expression patterns that correlated with survival in the preliminary group of patients. Most of these genes fell within four gene-expression signatures characteristic of germinal-center B cells, proliferating cells, reactive stromal and immune cells in the lymph node, or major-histocompatibility-complex class II complex. We used 17 genes to construct a predictor of overall survival after chemotherapy. This gene-based predictor and the international prognostic index were independent prognostic indicators. CONCLUSIONS: DNA microarrays can be used to formulate a molecular predictor of survival after chemotherapy for diffuse large-B-cell lymphoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationA Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A., & Miller, T. P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304083281404 · Cited by 2,149
Self-citationControl of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Davis, R. E., Brown, K. D., Siebenlist, U., & Staudt, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1861 · Cited by 1,051
Self-citationConnective tissue growth factor: a mediator of TGF-β action on fibroblasts
Grotendorst, G. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00010-5 · Cited by 761
Signatures of the Immune Response
Shaffer, A. L., Rosenwald, A., Hurt, E. M., Giltnane, J. M., Lam, L. T., Pickeral, O. K., & Staudt, L. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00194-7 · Cited by 314
Self-citationHuang, J. Z., Sanger, W. G., Greiner, T. C., Staudt, L. M., Weisenburger, D. D., Pickering, D. L., Lynch, J. C., Armitage, J. O., Warnke, R. A., Alizadeh, A. A., et al. (2002) · Blood · doi:10.1182/blood.v99.7.2285 · Cited by 290
Self-citationShipp, M. A., Abeloff, M. D., Antman, K. H., Carroll, G., Hagenbeek, A., Loeffler, M., Montserrat, E., Radford, J. A., Salles, G., Schmitz, N., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.423 · Cited by 251
Self-citation
Cited by
Items 101–200 of 204
The Evolution of Boosting Algorithms: From Machine Learning to Statistical Modelling
Binder, H., Gefeller, O., Schmid, M., & Mayr, A. (2014) · Methods of Information in Medicine · doi:10.3414/me13-01-0122 · Cited by 412
Diffuse large B-cell lymphoma—treatment approaches in the molecular era
Roschewski, M., Staudt, L. M., & Wilson, W. H. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.197 · Cited by 411
Self-citationThe emerging role of CXCL10 in cancer (Review)
LIU, M., GUO, S., & STILES, J. K. (2011) · Oncology Letters · doi:10.3892/ol.2011.300 · Cited by 411
Probabilistic model of the human protein-protein interaction network
Rhodes, D. R., Tomlins, S. A., Varambally, S., Mahavisno, V., Barrette, T., Kalyana-Sundaram, S., Ghosh, D., Pandey, A., & Chinnaiyan, A. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1103 · Cited by 410
Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Jost, P. J., & Ruland, J. (2007) · Blood · doi:10.1182/blood-2006-07-025809 · Cited by 408
Scott, D. W., Mottok, A., Ennishi, D., Wright, G. W., Farinha, P., Ben-Neriah, S., Kridel, R., Barry, G. S., Hother, C., Abrisqueta, P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.2383 · Cited by 405
Self-citationMikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401
Role of the proto-oncogene Pokemon in cellular transformation and ARF repression
Maeda, T., Hobbs, R. M., Merghoub, T., Guernah, I., Zelent, A., Cordon-Cardo, C., Teruya-Feldstein, J., & Pandolfi, P. P. (2005) · Nature · doi:10.1038/nature03203 · Cited by 401
Personalized Medicine: Progress and Promise
Chan, I. S., & Ginsburg, G. S. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101446 · Cited by 399
Optimally splitting cases for training and testing high dimensional classifiers
Dobbin, K. K., & Simon, R. M. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-31 · Cited by 392
Self-citationMorton, L. M., Turner, J. J., Cerhan, J. R., Linet, M. S., Treseler, P. A., Clarke, C. A., Jack, A., Cozen, W., Maynadié, M., Spinelli, J. J., et al. (2007) · Blood · doi:10.1182/blood-2006-11-051672 · Cited by 387
Self-citationColomo, L., López-Guillermo, A., Perales, M., Rives, S., Martı́nez, A., Bosch, F., Colomer, D., Falini, B., Montserrat, E., & Campo, E. (2003) · Blood · doi:10.1182/blood-2002-04-1286 · Cited by 391
Self-citationChoudhary, G. S., Al-harbi, S., Mazumder, S., Hill, B. T., Smith, M. R., Bodo, J., Hsi, E. D., & Almasan, A. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.525 · Cited by 390
Roadmap for Developing and Validating Therapeutically Relevant Genomic Classifiers
Simon, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8712 · Cited by 382
Self-citationClassification of lymphoid neoplasms: the microscope as a tool for disease discovery
Jaffe, E. S., Harris, N. L., Stein, H., & Isaacson, P. G. (2008) · Blood · doi:10.1182/blood-2008-07-077982 · Cited by 382
Self-citationB Cell Chronic Lymphocytic Leukemia: Lessons Learned from Studies of the B Cell Antigen Receptor
Chiorazzi, N., & Ferrarini, M. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141018 · Cited by 377
Multiple hypothesis testing in genomics
Goeman, J. J., & Solari, A. (2014) · Statistics in Medicine · doi:10.1002/sim.6082 · Cited by 375
Camilleri-Broët, S., Crinière, E., Broët, P., Delwail, V., Mokhtari, K., Moreau, A., Kujas, M., Raphaël, M., Iraqi, W., Sautès-Fridman, C., et al. (2006) · Blood · doi:10.1182/blood-2005-03-1024 · Cited by 371
Decaux, O., Lodé, L., Magrangeas, F., Charbonnel, C., Gouraud, W., Jézéquel, P., Attal, M., Harousseau, J.-L., Moreau, P., Bataille, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8545 · Cited by 371
Visco, C., Li, Y., Xu-Monette, Z. Y., Miranda, R. N., Green, T. M., Li, Y., Tzankov, A., Wen, W., Liu, W.-M., Kahl, B. S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.83 · Cited by 368
Savage, K. J., Chhanabhai, M., Gascoyne, R. D., & Connors, J. M. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh392 · Cited by 363
Self-citationCairo, M. S., Gerrard, M., Sposto, R., Auperin, A., Pinkerton, C. R., Michon, J., Weston, C., Perkins, S. L., Raphael, M., McCarthy, K., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036665 · Cited by 363
Friedberg, J. W., & Fisher, R. I. (2008) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2008.07.002 · Cited by 362
Self-citationNowakowski, G. S., LaPlant, B., Macon, W. R., Reeder, C. B., Foran, J. M., Nelson, G. D., Thompson, C. A., Rivera, C. E., Inwards, D. J., Micallef, I. N., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5714 · Cited by 359
Self-citationGene expression profiling of human sarcomas: insights into sarcoma biology.
Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1699 · Cited by 353
Cell cycle deregulation in B-cell lymphomas
Sánchez-Beato, M., Sánchez-Aguilera, A., & Piris, M. A. (2003) · Blood · doi:10.1182/blood-2002-07-2009 · Cited by 358
Non-Hodgkin Lymphoma: Diagnosis and Treatment
Ansell, S. M., & Armitage, J. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.8.1087 · Cited by 356
Self-citationFerrando, A. A., Armstrong, S. A., Neuberg, D. S., Sallan, S. E., Silverman, L. B., Korsmeyer, S. J., & Look, A. T. (2003) · Blood · doi:10.1182/blood-2002-10-3221 · Cited by 353
Lam, L. T., Wright, G., Davis, R. E., Lenz, G., Farinha, P., Dang, L., Chan, J. W., Rosenwald, A., Gascoyne, R. D., & Staudt, L. M. (2008) · Blood · doi:10.1182/blood-2007-09-111948 · Cited by 353
Self-citationChiaretti, S., Li, X., Gentleman, R., Vitale, A., Vignetti, M., Mandelli, F., Ritz, J., & Foa, R. (2004) · Blood · doi:10.1182/blood-2003-09-3243 · Cited by 351
Freidlin, B., & Simon, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0605 · Cited by 349
Self-citationClustering Algorithms in Biomedical Research: A Review
Xu, R., & Wunsch, D. C. (2010) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2010.2083647 · Cited by 349
Rimsza, L. M. (2004) · Blood · doi:10.1182/blood-2003-07-2365 · Cited by 344
Barshan, E., Ghodsi, A., Azimifar, Z., & Zolghadri Jahromi, M. (2011) · Pattern Recognition · doi:10.1016/j.patcog.2010.12.015 · Cited by 343
Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj001 · Cited by 342
Personalized medicine in oncology: the future is now
Schilsky, R. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3181 · Cited by 337
Bladder Cancer Outcome and Subtype Classification by Gene Expression
Blaveri, E., Simko, J. P., Korkola, J. E., Brewer, J. L., Baehner, F., Mehta, K., DeVries, S., Koppie, T., Pejavar, S., Carroll, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2409 · Cited by 337
Bodaghi, A., Fattahi, N., & Ramazani, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13323 · Cited by 336
RetractedFu, K., Weisenburger, D. D., Choi, W. W. L., Perry, K. D., Smith, L. M., Shi, X., Hans, C. P., Greiner, T. C., Bierman, P. J., Bociek, R. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9277 · Cited by 334
Self-citationThe landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Steen, C. B., Luca, B. A., Esfahani, M. S., Azizi, A., Sworder, B. J., Nabet, B. Y., Kurtz, D. M., Liu, C. L., Khameneh, F., Advani, R. H., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.011 · Cited by 332
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects
Burg, G., Kempf, W., Cozzio, A., Feit, J., Willemze, R., S. Jaffe, E., Dummer, R., Berti, E., Cerroni, L., Chimenti, S., et al. (2005) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2005.00495.x · Cited by 330
Zelenetz, A. D., Abramson, J. S., Advani, R. H., Andreadis, C. B., Byrd, J. C., Czuczman, M. S., Fayad, L., Forero, A., Glenn, M. J., Gockerman, J. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0021 · Cited by 329
Self-citationRubenstein, J. L., Fridlyand, J., Abrey, L., Shen, A., Karch, J., Wang, E., Issa, S., Damon, L., Prados, M., McDermott, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7311 · Cited by 327
Evaluating the Efficiency of Targeted Designs for Randomized Clinical Trials
Simon, R., & Maitournam, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0496 · Cited by 325
Self-citationA Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer
Lu, Y., Lemon, W., Liu, P.-Y., Yi, Y., Morrison, C., Yang, P., Sun, Z., Szoke, J., Gerald, W. L., Watson, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030467 · Cited by 323
Anti-CD20 Antibody Therapy for B-Cell Lymphomas
Maloney, D. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1114348 · Cited by 322
Rossille, D., Gressier, M., Damotte, D., Maucort-Boulch, D., Pangault, C., Semana, G., Le Gouill, S., Haioun, C., Tarte, K., Lamy, T., et al. (2014) · Leukemia · doi:10.1038/leu.2014.137 · Cited by 322
The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma
Park, S., Lee, J., Ko, Y. H., Han, A., Jun, H. J., Lee, S. C., Hwang, I. G., Park, Y. H., Ahn, J. S., Jung, C. W., et al. (2007) · Blood · doi:10.1182/blood-2007-01-067769 · Cited by 320
Ruan, J., Martin, P., Furman, R. R., Lee, S. M., Cheung, K., Vose, J. M., LaCasce, A., Morrison, J., Elstrom, R., Ely, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1142 · Cited by 319
Self-citationPredicting survival from microarray data—a comparative study
Bøvelstad, H. M., Nygård, S., Størvold, H. L., Aldrin, M., Borgan, Ø., Frigessi, A., & Lingjærde, O. C. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm305 · Cited by 318
Variation in Gene Expression Patterns in Human Gastric Cancers
Chen, X., Leung, S. Y., Yuen, S. T., Chu, K.-M., Ji, J., Li, R., Chan, A. S. Y., Law, S., Troyanskaya, O. G., Wong, J., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0833 · Cited by 316
Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
Wilson, W. H., Wright, G. W., Huang, D. W., Hodkinson, B., Balasubramanian, S., Fan, Y., Vermeulen, J., Shreeve, M., & Staudt, L. M. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.10.006 · Cited by 315
Self-citationUnderstanding intraocular lymphomas
Coupland, S. E., & Damato, B. (2008) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2008.01843.x · Cited by 313
Santin, A. D., Zhan, F., Bellone, S., Palmieri, M., Cane, S., Bignotti, E., Anfossi, S., Gokden, M., Dunn, D., Roman, J. J., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20408 · Cited by 313
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Honma, K., Tsuzuki, S., Nakagawa, M., Tagawa, H., Nakamura, S., Morishima, Y., & Seto, M. (2009) · Blood · doi:10.1182/blood-2008-12-194852 · Cited by 305
Hernandez‐Ilizaliturri, F. J., Deeb, G., Zinzani, P. L., Pileri, S. A., Malik, F., Macon, W. R., Goy, A., Witzig, T. E., & Czuczman, M. S. (2011) · Cancer · doi:10.1002/cncr.26135 · Cited by 304
The role of FDG-PET scans in patients with lymphoma
Seam, P., Juweid, M. E., & Cheson, B. D. (2007) · Blood · doi:10.1182/blood-2007-06-097238 · Cited by 304
Identification of pediatric septic shock subclasses based on genome-wide expression profiling
Wong, H. R., Cvijanovich, N., Lin, R., Allen, G. L., Thomas, N. J., Willson, D. F., Freishtat, R. J., Anas, N., Meyer, K., Checchia, P. A., et al. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-34 · Cited by 303
de Jong, D., Rosenwald, A., Chhanabhai, M., Gaulard, P., Klapper, W., Lee, A., Sander, B., Thorns, C., Campo, E., Molina, T., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4490 · Cited by 301
Self-citationGenomics and the Continuum of Cancer Care
McDermott, U., Downing, J. R., & Stratton, M. R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0907178 · Cited by 299
Ding, B. B., Yu, J. J., Yu, R. Y.-L., Mendez, L. M., Shaknovich, R., Zhang, Y., Cattoretti, G., & Ye, B. H. (2008) · Blood · doi:10.1182/blood-2007-04-087734 · Cited by 298
Iqbal, J., Neppalli, V. T., Wright, G., Dave, B. J., Horsman, D. E., Rosenwald, A., Lynch, J., Hans, C. P., Weisenburger, D. D., Greiner, T. C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4264 · Cited by 298
Self-citationFABIA: factor analysis for bicluster acquisition
Hochreiter, S., Bodenhofer, U., Heusel, M., Mayr, A., Mitterecker, A., Kasim, A., Khamiakova, T., Van Sanden, S., Lin, D., Talloen, W., et al. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq227 · Cited by 296
Persky, D. O., Unger, J. M., Spier, C. M., Stea, B., LeBlanc, M., McCarty, M. J., Rimsza, L. M., Fisher, R. I., & Miller, T. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.6929 · Cited by 294
Self-citationSalaverria, I., Philipp, C., Oschlies, I., Kohler, C. W., Kreuz, M., Szczepanowski, M., Burkhardt, B., Trautmann, H., Gesk, S., Andrusiewicz, M., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330795 · Cited by 292
Advantages and limitations of microarray technology in human cancer
Russo, G., Zegar, C., & Giordano, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206865 · Cited by 289
Mycosis fungoides and Sézary syndrome
Hwang, S. T., Janik, J. E., Jaffe, E. S., & Wilson, W. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60420-1 · Cited by 286
Self-citationDistinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
Hoefnagel, J. J., Dijkman, R., Basso, K., Jansen, P. M., Hallermann, C., Willemze, R., Tensen, C. P., & Vermeer, M. H. (2005) · Blood · doi:10.1182/blood-2004-04-1594 · Cited by 286
Online Feature Selection with Streaming Features
Wu, X., Yu, K., Ding, W., Wang, H., & Zhu, X. (2013) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2012.197 · Cited by 283
Genetics of diffuse large B-cell lymphoma
Pasqualucci, L., & Dalla-Favera, R. (2018) · Blood · doi:10.1182/blood-2017-11-764332 · Cited by 282
Segman, R. H., Shefi, N., Goltser-Dubner, T., Friedman, N., Kaminski, N., & Shalev, A. Y. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001636 · Cited by 281
Grogg, K. L., Miller, R. F., & Dogan, A. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.051953 · Cited by 281
Iqbal, J., Sanger, W. G., Horsman, D. E., Rosenwald, A., Pickering, D. L., Dave, B., Dave, S., Xiao, L., Cao, K., Zhu, Q., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63284-1 · Cited by 279
Self-citationThieblemont, C., Briere, J., Mounier, N., Voelker, H.-U., Cuccuini, W., Hirchaud, E., Rosenwald, A., Jack, A., Sundstrom, C., Cogliatti, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.4423 · Cited by 275
Self-citationNowakowski, G. S., Chiappella, A., Gascoyne, R. D., Scott, D. W., Zhang, Q., Jurczak, W., Özcan, M., Hong, X., Zhu, J., Jin, J., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01366 · Cited by 275
Self-citationRhodes, D. R., Sanda, M. G., Otte, A. P., Chinnaiyan, A. M., & Rubin, M. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.661 · Cited by 271
Tissue repair and regeneration with endogenous stem cells
Xia, H., Li, X., Gao, W., Fu, X., Fang, R. H., Zhang, L., & Zhang, K. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0027-6 · Cited by 268
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures
Kotlov, N., Bagaev, A., Revuelta, M. V., Phillip, J. M., Cacciapuoti, M. T., Antysheva, Z., Svekolkin, V., Tikhonova, E., Miheecheva, N., Kuzkina, N., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0839 · Cited by 267
Winter, J. N. (2006) · Blood · doi:10.1182/blood-2005-10-4222 · Cited by 265
Lessons from Controversy: Ovarian Cancer Screening and Serum Proteomics
Ransohoff, D. F. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji054 · Cited by 264
MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
Fontan, L., Yang, C., Kabaleeswaran, V., Volpon, L., Osborne, M. J., Beltran, E., Garcia, M., Cerchietti, L., Shaknovich, R., Yang, S. N., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.003 · Cited by 264
Self-citationLarge-scale attribute selection using wrappers
Gutlein, M., Frank, E., Hall, M., & Karwath, A. (2009) · 2009 IEEE Symposium on Computational Intelligence and Data Mining · doi:10.1109/cidm.2009.4938668 · Cited by 264
Molecular portraits and the family tree of cancer
Chung, C. H., Bernard, P. S., & Perou, C. M. (2002) · Nature Genetics · doi:10.1038/ng1038 · Cited by 262
The Biology of Human Lymphoid Malignancies Revealed by Gene Expression Profiling
Staudt, L. M., & Dave, S. (2005) · Advances in Immunology · doi:10.1016/s0065-2776(05)87005-1 · Cited by 260
Self-citationGene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer
Spentzos, D., Levine, D. A., Ramoni, M. F., Joseph, M., Gu, X., Boyd, J., Libermann, T. A., & Cannistra, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.070 · Cited by 255
Malumbres, R., Sarosiek, K. A., Cubedo, E., Ruiz, J. W., Jiang, X., Gascoyne, R. D., Tibshirani, R., & Lossos, I. S. (2009) · Blood · doi:10.1182/blood-2008-10-184077 · Cited by 252
Self-citationTurner, J. J., Morton, L. M., Linet, M. S., Clarke, C. A., Kadin, M. E., Vajdic, C. M., Monnereau, A., Maynadié, M., Chiu, B. C.-H., Marcos-Gragera, R., et al. (2010) · Blood · doi:10.1182/blood-2010-06-289561 · Cited by 231
Self-citationOn the efficiency of targeted clinical trials
Maitournam, A., & Simon, R. (2005) · Statistics in Medicine · doi:10.1002/sim.1975 · Cited by 200
Self-citationIlyas, H., Mikhaeel, N. G., Dunn, J. T., Rahman, F., Møller, H., Smith, D., & Barrington, S. F. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3953-z · Cited by 150
Hartmann, L. C., Lu, K. H., Linette, G. P., Cliby, W. A., Kalli, K. R., Gershenson, D., Bast, R. C., Stec, J., Iartchouk, N., Smith, D. I., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1673 · Cited by 141
de Charette, M., & Houot, R. (2018) · Haematologica · doi:10.3324/haematol.2017.184192 · Cited by 129
Porrata, L. F., Ristow, K., Habermann, T., Inwards, D. J., Micallef, I. N., & Markovic, S. N. (2010) · American Journal of Hematology · doi:10.1002/ajh.21849 · Cited by 124
NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms
Yu, L., Li, L., Medeiros, L. J., & Young, K. H. (2017) · Blood Reviews · doi:10.1016/j.blre.2016.10.001 · Cited by 105
Nakhoda, S., Vistarop, A., & Wang, Y. L. (2023) · British Journal of Haematology · doi:10.1111/bjh.18418 · Cited by 104
Carpio, C., Bouabdallah, R., Ysebaert, L., Sancho, J.-M., Salles, G., Cordoba, R., Pinto, A., Gharibo, M., Rasco, D., Panizo, C., et al. (2020) · Blood · doi:10.1182/blood.2019002395 · Cited by 72
Yang, C., Lu, P., Lee, F. Y., Chadburn, A., Barrientos, J. C., Leonard, J. P., Ye, F., Zhang, D., Knowles, D. M., & Wang, Y. L. (2008) · Leukemia · doi:10.1038/leu.2008.163 · Cited by 61
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas
Reimann, M., Schrezenmeier, J., Richter-Pechanska, P., Dolnik, A., Hick, T. P., Schleich, K., Cai, X., Fan, D. N. Y., Lohneis, P., Maßwig, S., et al. (2021) · Blood · doi:10.1182/blood.2020005244 · Cited by 59
Self-citationBone histomorphometric changes after liver transplantation for chronic cholestatic liver disease
Guichelaar, M. M., Malinchoc, M., Sibonga, J. D., Clarke, B. L., & Hay, J. E. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2190 · Cited by 50
Yoon, S.-B., Hong, H., Lim, H.-J., Choi, J. H., Choi, Y. P., Seo, S. W., Lee, H. W., Chae, C. H., Park, W.-K., Kim, H. Y., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.001 · Cited by 44
Metadata
- Authors
- Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Yang, L., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D., Powell, J., Duffey, P. L., Longo, D. L., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Montserrat, E., López-Guillermo, A., Grogan, T. M., Miller, T. P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T., & Staudt, L. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-06-20
- Volume
- 346
- Issue
- 25
- Pages
- 1937-1947
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1976564639
- Cited by
- 3,829
- References
- 16
- FWCI
- 110.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.